Immunization

>

Latest News

©Kateryna_Kon/stock.adobe.com
Merck's 21-Valent Adult-Specific Pneumococcal Vaccine Accrues New Phase 3 and Real World Data

March 19th 2024

The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.

Would you Know Measles if You Saw It?
Would you Know Measles if You Saw It?

March 18th 2024

Measles and the Collective American Memory: 3 Questions / image credit MMR vial:  ©Sherry Yates Young/Shutterstock.com
Measles and the Collective American Memory: 3 Questions

March 18th 2024

Influenza Vaccines: 4 Questions on What to Order, Which to Use ©Leigh Prather/stock.adobe.com
Influenza Vaccines: 4 Questions on What to Order, Which to Use

February 7th 2024

Updated Monovalent COVID-19 Vaccines Effective Against Symptomatic Infection, Emerging Variants / Image credit: ©Talia Mdlungu/peopleimages.com/AdobeStock
Updated Monovalent COVID-19 Vaccines Effective Against Symptomatic Infection, Emerging Variants

February 2nd 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.